Rinvoq ER 30 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DB25FX35E
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $5,099
Award facts
- Contract value 100% obligated
- $5,099.34 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $5,099.34 delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of RINVOQ ER 30 mg tablets (30-count units). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of August 25, 2025, and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. RINVOQ (upadacitinib) is a Janus kinase inhibitor used to treat rheumatoid arthritis and other inflammatory conditions, making this order part of the Defense Logistics Agency's ongoing procurement of pharmaceutical products for military and veteran healthcare systems.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and critical federal vendor, AmerisourceBergen maintains an extensive portfolio of competitively awarded contracts supplying brand-name and generic medications, vaccines, and specialized medical supplies to support military healthcare programs globally. The company's significant IDC with DLA positions it as a primary vendor for comprehensive pharmaceutical support across multiple therapeutic domains serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities.
Quick answers
Who was awarded contract SPE2DB25FX35E?
SPE2DB25FX35E was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 22, 2025.
How much is contract SPE2DB25FX35E worth?
The government has obligated $5,099 on SPE2DB25FX35E.
Is contract SPE2DB25FX35E an order under another contract?
Yes. SPE2DB25FX35E is a delivery order under SPE2DB20D2200, an indefinite delivery contract.
Was contract SPE2DB25FX35E competed?
The extent of competition for SPE2DB25FX35E was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award